SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Contingent Liabilities | ₹85 Cr | ₹85 Cr | ₹84 Cr | ₹84 Cr |
What is the latest Contingent Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹85 Cr |
| Mar2025 | ₹85 Cr |
| Mar2024 | ₹84 Cr |
| Mar2023 | ₹84 Cr |
How is Contingent Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹85 Cr | -0.06 | |
| Mar2025 | ₹85 Cr | 1.47 | |
| Mar2024 | ₹84 Cr | 0.00 | |
| Mar2023 | ₹84 Cr | - | |
Compare Contingent Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹5,573.3 Cr | -9% | -13.2% | 31.4% | Stock Analytics | |
| PRIME FOCUS | ₹21,225.5 Cr | -6% | -23.8% | 60.3% | Stock Analytics | |
| SAGILITY | ₹20,644.7 Cr | -2.5% | -3.1% | -0.7% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹16,521.5 Cr | 16.9% | 16.9% | 3% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹14,810.6 Cr | -5.1% | -2.9% | -41.9% | Stock Analytics | |
| INDEGENE | ₹13,772.2 Cr | -4.5% | -3.6% | 9.1% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -9% |
-13.2% |
31.4% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses